A
Anthony Ragheb
Publications - 12
Citations - 1142
Anthony Ragheb is an academic researcher. The author has contributed to research in topics: Stent & Drug-eluting stent. The author has an hindex of 7, co-authored 12 publications receiving 971 citations.
Papers
More filters
Journal ArticleDOI
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results
Michael D. Dake,Gary M. Ansel,Michael R. Jaff,Takao Ohki,Richard R. Saxon,H. Bob Smouse,Thomas Zeller,Gary S. Roubin,Mark W. Burket,Yazan Khatib,Scott A. Snyder,Anthony Ragheb,J. King White,Lindsay S. Machan +13 more
TL;DR: Femoropopliteal peripheral artery disease treatment with the paclitaxel-eluting stent was associated with superior 12-month outcomes compared with PTA and provisional bare metal stent placement.
Journal ArticleDOI
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
Michael D. Dake,Gary M. Ansel,Michael R. Jaff,Takao Ohki,Richard R. Saxon,H. Bob Smouse,Lindsay S. Machan,Scott A. Snyder,Erin E. O’Leary,Anthony Ragheb,Thomas Zeller +10 more
TL;DR: In this paper, a randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions.
Journal ArticleDOI
Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee: Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study:
Michael D. Dake,Dierk Scheinert,Gunnar Tepe,Jörg Tessarek,Fabrizio Fanelli,Marc Bosiers,Christof Ruhlmann,Zaza Kavteladze,Aaron E. Lottes,Anthony Ragheb,Thomas Zeller +10 more
TL;DR: The results indicate that the Zilver PTX drug-eluting stent is safe for treatment of patients with de novo and restenotic lesions of the above-the-knee femoropopliteal segment and the overall anatomical and clinical effectiveness results suggest that thisStent is a promising endovascular therapy.
Journal ArticleDOI
Polymer-free paclitaxel-coated Zilver PTX Stents--evaluation of pharmacokinetics and comparative safety in porcine arteries.
TL;DR: The Zilver PTX stent appears to be safe, achieves sustained paclitaxel levels in the artery wall, and shows complete vessel healing comparable to bare metal stents within 3 months.
Journal ArticleDOI
Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries
Sho Torii,Kazuyuki Yahagi,Hiroyoshi Mori,Emanuel Harari,Maria Romero,Frank D. Kolodgie,Brandt Young,Anthony Ragheb,Renu Virmani,Aloke V. Finn +9 more
TL;DR: In the treated arteries, irrespective of preceding DCB treatment or PTA, DES treatment showed maximum drug effects vs DCB alone or in combination with BMS placement, and there was no detrimental toxic effect in DCB-treated iliofemoral arteries beforeDES treatment compared with PTA before DES treatment.